Chemipharm Executive and Leadership Team

Karim Kamel, the Chief Executive Officer at Chemipharm, directs the overarching corporate strategy and long-term vision. This leadership role involves guiding the company's expansion efforts, including the development of its manufacturing facility and the ongoing construction of a new sterile area for specialized pharmaceutical production. Karim Kamel ensures alignment with the company's mission to continuously improve and grow its market presence within Egypt. The Chief Executive Officer oversees all major strategic initiatives, driving Chemipharm's commitment to being the leading pharmaceutical distributor. This involves fostering innovation and maintaining the high standards that have defined the company since its inception. The Chief Executive Officer's focus remains on strengthening Chemipharm's unique position of selling directly to 100% of reachable pharmacies and hospitals across Egypt, leveraging the extensive distribution network of 12 branches and 100 daily routes.

Rafik Nessim, the Chief Operating Officer at Chemipharm, manages the day-to-day operational execution and efficiency of the company's extensive distribution network. This involves optimizing the logistics of 100 fixed routes and 150 daily visits that reach all pharmacies nationwide, ensuring timely delivery of pharmaceutical products. Rafik Nessim oversees the operational integration of Chemipharm's 12 branches across Egypt, driving seamless service delivery. The Chief Operating Officer plays a critical part in maintaining the high standards of pharmaceutical distribution that Chemipharm is known for. By focusing on operational excellence, Nessim supports the company's strategy of continuous improvement and growth. This leadership position ensures the robust functioning of the supply chain, directly impacting Chemipharm's ability to serve 100% of reachable pharmacies and hospitals in Egypt. The Chief Operating Officer's responsibilities extend to enhancing the efficiency of the manufacturing facility in the 6th of October Industrial Zone.

Nedal Melika, the Deputy Chief Operating Officer at Chemipharm, supports the Chief Operating Officer in executing the company's complex logistical operations across Egypt. This role involves assisting in the management of the 12 branches and ensuring the consistent daily operation of 100 fixed routes and 150 visiting points that cover the entire country. Nedal Melika focuses on enhancing the efficiency and reliability of Chemipharm's distribution network, crucial for reaching all reachable pharmacies and hospitals. The Deputy Chief Operating Officer contributes to maintaining the company's reputation for high standards in pharmaceutical distribution. Melika's efforts are directed towards operational improvements that support Chemipharm's strategy of continuous growth. This involves close collaboration with the operations team to ensure seamless product flow from the manufacturing facility to the end customer. The Deputy Chief Operating Officer's work is vital for the sustained success of Chemipharm's market penetration strategy.

Doulas Oliver, the President at Chemipharm, provides strategic leadership and oversight, particularly concerning the company's manufacturing operations and future development. This involves guiding the expansion of the modern GMP plant in the 6th of October Industrial Zone, including the construction of a new sterile area for ampoules, eye drops, and antibiotics. Doulas Oliver ensures that manufacturing processes adhere to the highest standards, supporting Chemipharm's commitment to quality and growth. The President's role is integral to advancing the company's strategy of continuous improvement and expanding its product offerings. Oliver's leadership influences the integration of new production capabilities with the existing distribution network, reinforcing Chemipharm's position as a leading pharmaceutical importer and distributor in Egypt. The President's focus is on driving innovation within the manufacturing sector, ensuring Chemipharm remains at the forefront of pharmaceutical production and distribution.